Skip to main content

Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease


Background and aims

High blood pressure (HBP) is a common comorbidity in psoriatic disease. Some studies indicate a higher prevalence of HBP among arthritis patients, in relation to psoriasis alone, within the psoriatic spectrum. Our objective was to study the prevalence of HBP in both types of patients as well as to analyse the factors associated with it.


A cross-sectional observational study of 600 patients with psoriatic disease attended in a multidisciplinary clinic of a reference centre. We first analysed the frequency of this comorbidity and then the factors associated with it using conditional logistic regression. The significant factors in this first model were introduced in a multivariate model using a backward step approach.


A total of 144 patients were hypertensive (24%). Of patients with arthritis, 86/290 (29.7%) had HBP, compared with 58/310 (18.7%) with psoriasis (OR 1.7 95%, CI 1.25–2.50, p = 0.003). Hypertension was independently associated with higher age at onset of psoriasis (OR 1.04, 95%CI 1.03–1.06, p < 0.001) and a higher body mass index (OR 1.13, 95%CI, 1.06–1.22, p < 0.001).


HBP is more prevalent in patients with arthritis within the spectrum of psoriatic disease. Patients with a higher body mass index and those with later-onset psoriasis are more prone to this comorbidity.

Key Points

• The factors of psoriatic disease associated with HBP are little known.

• HBP is more prevalent in patients with arthritis within the spectrum of psoriatic disease.

• In patients with psoriatic disease, for each point of increase in the body mass index, the risk of HBP increases by 13%.

• For each year of onset of psoriasis above 40 years, the risk of HBP increases by 4%.

This is a preview of subscription content, access via your institution.


  1. Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am 41:545–568

    Article  Google Scholar 

  2. Scarpa R, Caso F, Costa L, Peluso R, Del Puente A, Olivieri I (2017) Psoriatic disease 10 years later. J Rheumatol 44:1298–1301

    Article  CAS  PubMed  Google Scholar 

  3. Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97–105

    Article  CAS  PubMed  Google Scholar 

  4. Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169:783–793

    Article  CAS  PubMed  Google Scholar 

  5. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63:1729–1735

    Article  Google Scholar 

  6. González-Juanatey C, Llorca J, Amigo-Díaz E, Dierssen T, Martín J, González-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080

    Article  PubMed  Google Scholar 

  7. Eder L, Chandran V, Gladman DD (2014) The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73:1990–1996

    Article  PubMed  Google Scholar 

  8. Armstrong AW, Harskamp CT, Armstrong EJ (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 31:433–443

    Article  CAS  PubMed  Google Scholar 

  9. Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB, Gelfand JM (2015) Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol 151:161–169

    Article  PubMed  PubMed Central  Google Scholar 

  10. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673

    Article  PubMed  Google Scholar 

  11. Queiro R, Coto P (2017) Multidisciplinary care for psoriatic disease: where we are and where we need to go. Rheumatology (Oxford) 56:1829–1831

    Google Scholar 

  12. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783

    Article  CAS  PubMed  Google Scholar 

  13. Queiro R, Lorenzo A, Tejón P, Pardo E, Coto P, Ballina J (2018) Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis. Int J Rheum Dis 22:269–274.

    Article  PubMed  Google Scholar 

  14. Queiro R, Tejón P, Alonso S, Coto P (2014) Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology (Oxford) 53:1178–1185

    Article  CAS  Google Scholar 

  15. Alonso S, Tejón P, Sarasqueta C, Coto P, Alperi M, Queiro R (2016) Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis. Joint Bone Spine 83:533–537

    Article  CAS  PubMed  Google Scholar 

  16. Bonifati C, Mussi A, Carducci M, Pittarello A, D'Auria L, Venuti A et al (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78:22–26

    Article  CAS  PubMed  Google Scholar 

  17. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552–2564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Puig L (2018) Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci 19:58

    Article  CAS  Google Scholar 

  20. Lin YC, Dalal D, Churton S, Brennan DM, Korman NJ, Kim ES et al (2014) Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res 66:97–103

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Rubén Queiro.

Ethics declarations



Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Queiro, R., Lorenzo, A., Tejón, P. et al. Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease. Clin Rheumatol 38, 2063–2068 (2019).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Comorbidity
  • High blood pressure
  • Psoriasis
  • Psoriatic arthritis